.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Merck
Chinese Patent Office
Healthtrust
US Department of Justice
Harvard Business School
Citi
Teva
Boehringer Ingelheim
Moodys

Generated: September 21, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Summary for Patent: ► Subscribe

Title: Pharmaceutically stable preparation of oxaliplatinum
Abstract:A pharmaceutically stable oxaliplatinum preparation for parenteral administration comprises an aqueous solution of oxaliplatinum, in a concentration of 1 to 5 mg/ml, and with a pH in the range of 4.5 to 6. The aqueous oxaliplatinum solution is advantageously provided as a ready-to-use preparation in a sealed container.
Inventor(s): Ibrahim; Houssam (Veyrier, CH), Mauvernay; Rolland-Yves (Lausanne, CH)
Assignee: Debiopharm S.A. (Lausanne, CH)
Application Number:08/776,240
Patent Claim Types:
see list of patent claims
Formulation; Device;

No matches for this query

Foreign Priority and PCT Information for Patent: ► Subscribe

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Switzerland2462/94Aug 08, 1994
PCT Information
PCT FiledAugust 07, 1995PCT Application Number:PCT/IB95/00614
PCT Publication Date:February 22, 1996PCT Publication Number: WO96/04904

International Patent Family for Patent: ► Subscribe

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Germany69519300► Subscribe
Australia2252499► Subscribe
Australia2989695► Subscribe
Brazil9508554► Subscribe
Canada2196922► Subscribe
China1154654► Subscribe
China1138541► Subscribe
Czech Republic286714► Subscribe
Czech Republic9700379► Subscribe
Australia731981► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Argus Health
Federal Trade Commission
Colorcon
Cerilliant
Chinese Patent Office
Boehringer Ingelheim
US Department of Justice
Baxter
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot